Abeona Therapeutics Inc vs Teucrium Wheat Fund — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Teucrium Wheat Fund trades at $24.15. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, Teucrium Wheat Fund nearer its low. Which is the better fit depends on your goals.
| ABEO | WEAT | |
|---|---|---|
Market Cap | $421.19M | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $7.45 | $26.00 |
52-Week Low | $4.17 | $19.88 |
Enterprise Value | $276.10M | — |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →WEAT is a commodity ETF that provides exposure to the price of wheat futures. It employs a laddered strategy across multiple benchmark contracts to mitigate the effects of contango and roll costs inherent in agricultural futures trading.
Read more on WEAT →